RXST RxSight Inc
- Stocks
- Healthcare
- NASDAQ: RXST
Price (delayed)
$8.82
Market cap
$360.88M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.8
Enterprise value
$331.49M
Relative Growth:
Rel. Growth:
53
Relative Strength:
Rel. Strength:
6
Relative Valuation:
Rel. Valuation:
21
Relative Profitability:
Rel. Profitability:
36
Highlights
RXST's gross profit is up by 41% YoY
RXST's revenue is up by 28% year-on-year
The EPS has grown by 21% year-on-year but it has declined by 19% since the previous quarter
RXST's net income is down by 21% since the previous quarter but it is up by 12% year-on-year
Sector: Healthcare
Industry: Medical Devices
Key stats
What are the main financial stats of RXST
Market
Valuations
Earnings
Shares outstanding
40.92M
Market cap
$360.88M
Enterprise value
$331.49M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.29
Price to sales (P/S)
2.44
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.25
Revenue
$147.06M
Gross profit
$107.53M
Operating income
-$42.53M
Net income
-$32.25M
EBIT
-$32.16M
EBITDA
-$28.93M
Free cash flow
-$20.88M
Per share
Balance sheet
Liquidity
EPS
-$0.8
EPS diluted
-$0.8
Free cash flow per share
-$0.51
Book value per share
$6.84
Revenue per share
$3.61
TBVPS
$7.58
Total assets
$309.01M
Total liabilities
$31M
Debt
$11.72M
Equity
$278.01M
Working capital
$263.49M
Debt to equity
0.04
Current ratio
13.93
Quick ratio
12.57
Net debt/EBITDA
1.02
Margins
Efficiency
Dividend
EBITDA margin
-19.7%
Gross margin
73.1%
Net margin
-21.9%
Operating margin
-28.9%
Return on assets
-10.3%
Return on equity
-11.6%
Return on invested capital
-11.7%
Return on capital employed
-11.1%
Return on sales
-21.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RXST stock price
How has the RxSight stock price performed over time
Intraday
5.76%
1 week
2.68%
1 month
3.89%
1 year
-83.88%
YTD
-74.35%
QTD
-1.89%
Financial performance
How have RxSight's revenue and profit performed over time
Revenue
$147.06M
Gross profit
$107.53M
Operating income
-$42.53M
Net income
-$32.25M
Gross margin
73.1%
Net margin
-21.9%
RXST's gross profit is up by 41% YoY
RxSight's net margin has increased by 31% YoY but it has decreased by 22% from the previous quarter
RXST's revenue is up by 28% year-on-year
The company's operating margin rose by 21% YoY but it fell by 16% QoQ
Price vs fundamentals
How does RXST's price correlate with its fundamentals
Growth
What is RxSight's growth rate over time
Valuation
What is RxSight stock price valuation
P/E
N/A
P/B
1.29
P/S
2.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.25
The EPS has grown by 21% year-on-year but it has declined by 19% since the previous quarter
RXST's P/B is 76% below its 5-year quarterly average of 5.1 and 72% below its last 4 quarters average of 4.4
RXST's P/S is 80% below its 5-year quarterly average of 11.5 and 74% below its last 4 quarters average of 8.8
RXST's revenue is up by 28% year-on-year
Efficiency
How efficient is RxSight business performance
RxSight's return on invested capital has increased by 43% YoY but it has decreased by 23% QoQ
The ROA has increased by 40% YoY but it has decreased by 21% from the previous quarter
RXST's ROE is up by 40% YoY but it is down by 22% QoQ
The return on sales has grown by 31% year-on-year but it has declined by 23% since the previous quarter
Dividends
What is RXST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RXST.
Financial health
How did RxSight financials performed over time
The company's current ratio rose by 10% QoQ but it fell by 2.8% YoY
RxSight's quick ratio has increased by 9% from the previous quarter but it has decreased by 5% YoY
RxSight's debt is 96% less than its equity
RxSight's debt has decreased by 2.7% from the previous quarter but it has increased by 2.7% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.